Ask AI
ProCE Banner Activity

Myelofibrosis: Emerging Therapeutic Strategies and Managing Patients Intolerant/Resistant to Ruxolitinib

Slideset Download
Download this slideset for expert perspectives on emerging therapies and optimal management of patients with myelofibrosis that is intolerant/resistant to ruxolitinib.

Released: December 06, 2019

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Celgene

CTI BioPharma Corp., a Sobi Company

Geron

Faculty Disclosure

Primary Author

Raajit K. Rampal, MD, PhD

Director
MPN and Rare Hematologic Disease Program
New York, New York